Background Last year, the authors and other BRG professionals discussed how pharmaceutical manufacturers needed to assess the financial impacts and potential impact scenarios on each drug-pricing provision of the Inflation Reduction Act (IRA). The IRA has and will continue to have a significant impact on the pharmaceutical industry.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile